BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic hepatitis C
1
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
4/29/2021 2:12:02 AM | Browse: 36 | Download: 71
2
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 190 | Download: 307
3
Liver-related effects of chronic hepatitis C antiviral treatment
6/14/2020 1:45:26 PM | Browse: 272 | Download: 368
4
Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus
4/23/2020 10:34:55 AM | Browse: 219 | Download: 402
5
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 364 | Download: 469
6
Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy
8/26/2019 2:56:47 AM | Browse: 274 | Download: 581
7
High prevalence of occult hepatitis C infection in predialysis patients
1/27/2019 7:04:05 AM | Browse: 383 | Download: 472
8
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM | Browse: 348 | Download: 396
9
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
3/26/2018 8:48:04 AM | Browse: 678 | Download: 804
10
Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis
1/26/2018 8:09:36 AM | Browse: 564 | Download: 564
11
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 593 | Download: 773
12
Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment
7/7/2017 11:41:16 AM | Browse: 616 | Download: 851
13
Interferon related pericarditis: Review
6/26/2017 12:49:43 AM | Browse: 639 | Download: 495
14
Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
6/14/2017 9:25:57 AM | Browse: 625 | Download: 876
15
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 1124 | Download: 2040
16
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM | Browse: 876 | Download: 854
17
Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
4/6/2017 6:30:00 PM | Browse: 794 | Download: 821
18
Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C
2/27/2017 8:50:00 AM | Browse: 579 | Download: 729
19
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
2/17/2017 8:32:00 AM | Browse: 700 | Download: 671
20
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
11/26/2016 6:56:00 PM | Browse: 667 | Download: 1095
21
Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature
11/6/2016 3:43:00 PM | Browse: 595 | Download: 499
22
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
10/14/2016 1:37:00 PM | Browse: 615 | Download: 552
23
Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
9/30/2016 5:59:00 PM | Browse: 792 | Download: 1187
24
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
9/4/2016 2:49:00 PM | Browse: 808 | Download: 878
25
Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles
7/29/2016 8:32:00 PM | Browse: 598 | Download: 829
26
Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
4/19/2016 9:45:00 AM | Browse: 652 | Download: 1174
27
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
3/23/2016 4:26:00 PM | Browse: 782 | Download: 1185
28
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage
1/20/2016 5:04:00 PM | Browse: 788 | Download: 691
29
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver
12/10/2015 10:35:00 AM | Browse: 647 | Download: 710
30
Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching
12/4/2015 3:24:00 PM | Browse: 700 | Download: 1122
31
Treatment of chronic hepatitis C in patients with HIV/HCV coinfection
12/2/2015 12:06:00 PM | Browse: 316 | Download: 522
32
Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C
11/18/2015 11:12:00 AM | Browse: 620 | Download: 570
33
Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C
11/18/2015 11:12:00 AM | Browse: 694 | Download: 921
34
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
10/30/2015 11:57:00 AM | Browse: 1103 | Download: 989
35
Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals
10/14/2015 12:06:00 PM | Browse: 697 | Download: 831
36
Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment
9/23/2015 12:28:00 PM | Browse: 1348 | Download: 957
37
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
8/8/2015 3:25:00 PM | Browse: 635 | Download: 1248
38
Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers
7/30/2015 11:19:00 AM | Browse: 809 | Download: 837
39
Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: a case report and systematic review of literature
6/29/2015 5:40:00 PM | Browse: 588 | Download: 682
40
Impact of direct acting antiviral-based triple therapy on the serum alpha-fetoprotein level
4/30/2015 2:11:00 PM | Browse: 655 | Download: 963
41
Management of hepatitis C infection before and after liver transplantation
4/30/2015 2:11:00 PM | Browse: 668 | Download: 765
42
Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C
4/7/2015 6:08:00 PM | Browse: 636 | Download: 815
43
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: a prospective pilot study
3/16/2015 6:04:00 PM | Browse: 667 | Download: 651
44
Protracted anaphylaxis developed after peginterferon -2a administration for chronic hepatitis C
3/9/2015 3:58:00 PM | Browse: 704 | Download: 771
45
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings
2/11/2015 5:56:00 PM | Browse: 961 | Download: 1097
46
Retreatment with peginterferon and ribavirin in chronic hepatitis C
2/11/2015 5:56:00 PM | Browse: 652 | Download: 738
47
Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: First case report
1/20/2015 9:10:00 PM | Browse: 667 | Download: 637
48
Hepatitis C and kidney disease: An overview and approach to management
1/10/2015 4:31:00 PM | Browse: 733 | Download: 776
49
Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection
12/5/2014 11:43:00 AM | Browse: 739 | Download: 807
50
Psoriasis: Biologic treatment and liver disease
11/13/2014 4:59:00 PM | Browse: 1051 | Download: 806